| ||||||||||||||
|
|
|||||||||||||

Departments of *Receptor Biochemistry and
Molecular Pharmacology, GlaxoSmithKline, Research Triangle Park, North Carolina
Address correspondence and reprint requests to Richard F. Cox, PhD, Systems Research, GlaxoSmithKline, Research Triangle Park, NC 27709. Address e-mail to rc7694{at}glaxowellcome.com
We performed in vitrostudies to investigate the potential interaction of benzodiazepines with cloned human opioid receptor subtypes. Midazolam, chlordiazepoxide, and diazepam directly displaced [3H]-diprenorphine binding from
and
receptors, but not µ receptors, whereas flumazenil was inactive. These benzodiazepines also stimulated 35S-GTP
S binding in membranes containing human
receptors, and the effect of midazolam was prevented by a selective
antagonist. Midazolam was also weakly active at
-receptor activation, whereas all three were inactive at µ receptors. The results suggest that the analgesic efficacy reported for intrathecal benzodiazepines may be attributed, in part, to direct interaction with
-opioid receptors.
IMPLICATIONS: Several human and animal studies have shown analgesic effects of benzodiazepines after spinal injection. Our results show that large concentrations of midazolam, chlordiazepoxide, and diazepam displace the binding of [3H]-diprenorphinean opiate radioligand from
receptors. In an in vitrofunctional assay, midazolam is a weak agonist at the
-opioid receptor, whereas all three benzodiazepines are
-opioid agonists. These findings may partially explain the mechanism of benzodiazepine-induced spinal analgesia.
This article has been cited by other articles:
![]() |
Y. K. Batra, R. Mahajan, S. Kumar, S. Rajeev, and M. Singh Dhillon A Dose-Ranging Study of Intraarticular Midazolam for Pain Relief After Knee Arthroscopy Anesth. Analg., August 1, 2008; 107(2): 669 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamamoto, J. Yamada, S. Ueno, H. Kubota, T. Furukawa, S. Yamamoto, and A. Fukuda Insertion of {alpha}7 Nicotinic Receptors at Neocortical Layer V GABAergic Synapses Is Induced by a Benzodiazepine, Midazolam Cereb Cortex, March 1, 2007; 17(3): 653 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Scaife, R. H. Hou, E. R. Samuels, F. Baqui, R. W. Langley, C. M. Bradshaw, and E. Szabadi Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing J Psychopharmacol, January 1, 2007; 21(1): 93 - 101. [Abstract] [PDF] |
||||
![]() |
J. C. Scaife, R. W. Langley, C. M. Bradshaw, and E. Szabadi Diazepam suppresses the acquisition but not the expression of 'fearpotentiation' of the acoustic startle response in man J Psychopharmacol, July 1, 2005; 19(4): 347 - 356. [Abstract] [PDF] |
||||
![]() |
S W Borron, C Monier, P Risede, and F J Baud Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat Human and Experimental Toxicology, November 1, 2002; 21(11): 599 - 605. [Abstract] [PDF] |
||||
|